The roles of interleukin‐1 receptor accessory protein in certain inflammatory conditions A Zarezadeh Mehrabadi, N Aghamohamadi, M Khoshmirsafa, ... Immunology 166 (1), 38-46, 2022 | 20 | 2022 |
Catalase application in cancer therapy: Simultaneous focusing on hypoxia attenuation and macrophage reprogramming A Najafi, M Keykhaee, H Khorramdelazad, MY Karimi, LN Samimi, ... Biomedicine & Pharmacotherapy 153, 113483, 2022 | 14 | 2022 |
Type-I interferons in the immunopathogenesis and treatment of Coronavirus disease 2019 H Khorramdelazad, MH Kazemi, M Azimi, A Aghamajidi, AZ Mehrabadi, ... European journal of pharmacology 927, 175051, 2022 | 12 | 2022 |
Age-Dependent Immune Responses in COVID-19-mediated Liver Injury: Focus on Cytokines N Aghamohamadi, F Shahba, A Zarezadeh Mehrabadi, ... Frontiers in Endocrinology 14, 1139692, 2023 | 5 | 2023 |
Comprehensive assessment of skin disorders in patients with common variable immunodeficiency (CVID) A Zarezadeh Mehrabadi, N Aghamohamadi, H Abolhassani, ... Journal of Clinical Immunology 42 (3), 653-664, 2022 | 5 | 2022 |
Interleukin-1 receptor accessory protein (IL-1RAP): A magic bullet candidate for immunotherapy of human malignancies AZ Mehrabadi, F Shahba, H Khorramdelazad, N Aghamohammadi, ... Critical Reviews in Oncology/Hematology 193, 104200, 2024 | 2 | 2024 |
Catalase-gold nanoaggregates manipulate the tumor microenvironment and enhance the effect of low-dose radiation therapy by reducing hypoxia A Najafi, M Keykhaee, MH Kazemi, MY Karimi, H Khorramdelazad, ... Biomedicine & Pharmacotherapy 167, 115557, 2023 | 2 | 2023 |
Activated PI3K-Delta syndrome: pathogenesis, clinical manifestations, diagnosis, classification, and management N Aghamohamadi, AZ Mehrabadi Immunology and Genetics Journal, 8-15, 2020 | 2 | 2020 |
The Role of Intra-Tumor Hypoxia in Cancer Cells Immune Escape Mechanism P Farhangnia, AA Delbandi, N Aghamohammadi, AR Safdarian, ... Handbook of Cancer and Immunology, 1-50, 2023 | 1 | 2023 |